Related references
Note: Only part of the references are listed.Considerations in the approach to invasive fungal infection in patients with haematological malignancies
Eric J. Bow
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients
Penelope D. Barnes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts
S. C. Metcalf et al.
JOURNAL OF INFECTION (2007)
The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in Immunocompromised patients
Cornelia Lass-Floerl et al.
CLINICAL INFECTIOUS DISEASES (2007)
Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients
M. J. Post et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Invasive aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality
Arlo Upton et al.
CLINICAL INFECTIOUS DISEASES (2007)
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders
Johan Maertens et al.
MYCOSES (2007)
New agents for the treatment of fungal infections: Clinical efficacy and gaps in coverage
Elias K. Spanakis et al.
CLINICAL INFECTIOUS DISEASES (2006)
Clinical efficacy of new antifungal agents
Carol A. Kauffman
CURRENT OPINION IN MICROBIOLOGY (2006)
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients:: A 6-year survey
A. Cornillet et al.
CLINICAL INFECTIOUS DISEASES (2006)
Candidaemia and antifungal therapy in a French University Hospital:: rough trends over a decade and possible links
Boualem Sendid et al.
BMC INFECTIOUS DISEASES (2006)
Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: A 1-year retrospective study of consecutive patients at French transplantation centers
C Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2006)
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study
M Boeckh et al.
BLOOD (2006)
Advances and challenges in management of invasive mycoses
TF Patterson
LANCET (2005)
Aspergillus infections in transplant recipients
N Singh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immuncisuppressed patients
C Lass-Florl et al.
MYCOSES (2005)
Ltraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
KA Marr et al.
BLOOD (2004)
Aspergillus terreus - An emerging amphotericin B-resistant opportunistic mold in patients with Hematologic malignancies
RY Hachem et al.
CANCER (2004)
Combination antifungal therapy for invasive aspergillosis
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2004)
Disseminated infection with Prototheca zopfii after unrelated stem cell transplantation for leukemia
C Lass-Flörl et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Treatment of fungal infections in hematology and oncology -: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
A Böhme et al.
ANNALS OF HEMATOLOGY (2003)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
KA Marr et al.
BLOOD (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Epidemiology of invasive aspergillosis in France:: a six-year multicentric survey in the Greater Paris area
M Cornet et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2002)
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation:: incidence and risk factors in 395 patients
R Martino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
